{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:02:55Z","timestamp":1740128575754,"version":"3.37.3"},"reference-count":75,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis & Ecotoxicology Reviews"],"published-print":{"date-parts":[[2005,4,6]]},"DOI":"10.1081\/gnc-200051856","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T18:21:38Z","timestamp":1126030898000},"page":"31-53","source":"Crossref","is-referenced-by-count":29,"title":["Physiologically-Based Pharmacokinetic and Toxicokinetic Models in Cancer Risk Assessment"],"prefix":"10.1081","volume":"23","author":[{"given":"Kannan","family":"Krishnan1<\/sup>,2<\/sup>","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Johanson2<\/sup>","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0163-7258(81)90097-8","volume":"12","author":"Wagner J","year":"1981","unstructured":"Wagner, J. (1981) History of pharmacokinetics Pharmacol Ther<\/i>, 12, pp. 537 - 562. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Pharmacol Ther"},{"key":"E00002","first-page":"101","author":"RenwickA","year":"2003","unstructured":"Renwick, A.(2003) Toxicokinetics-Pharmacokinetics In Toxicology. In Principles and Methods of Toxicology<\/i>. ( pp. 101 - 147 ). New York : Raven Press."},{"key":"E00003","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1289\/ehp.0211085","volume":"110","author":"Clewell H","year":"2002","unstructured":"Clewell, H and Andersen, M and Barton, H. (2002) A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment Environ Health Perspect<\/i>, 110(1), pp. 85 - 93. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>","journal-title":"Environ Health Perspect"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0048-9697(01)00744-6","volume":"274","author":"Andersen M","year":"2001","unstructured":"Andersen, M and Dennison, J. (2001) Mode of action and tissue dosimetry in current and future risk assessments Sci Tot Environ<\/i>, 274, pp. 3 - 14. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Sci Tot Environ"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-008X(88)90155-X","volume":"95","author":"Reitz R","year":"1998a","unstructured":"Reitz, R and McDougal, J and Himmelstein, M and Nolan, R and Schumann, A. (1998a) Physiologically-based pharmacokinetic modeling with methyl chloroform: Implications for interspecies, high-low dose and dose-route extrapolations Toxicol Appl Pharmacol<\/i>, 95, pp. 185 - 199. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0041-008X(90)90357-Z","volume":"105","author":"Reitz R","year":"1990","unstructured":"Reitz, R and McCroskey, P and Park, C and Andersen, M and Gargas, M. (1990) Development of a physiologically-based pharmacokinetic model for risk assessment with 1,4-dioxane Toxicol Appl Pharmacol<\/i>, 105, pp. 37 - 54. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-4274(90)90207-3","volume":"51","author":"Leung H","year":"1990","unstructured":"Leung, H and Paustenbach, D. (1990) Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic modeling approach Toxicol Lett<\/i>, 51, pp. 147 - 162. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Lett"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-008X(87)90281-X","volume":"87","author":"Andersen M","year":"1987","unstructured":"Andersen, M and Clewell, H and Gargas, M and Smith, F and Reitz, R. (1987) Physiologically-based pharmacokinetics and risk assessment process for methylene chloride Toxicol Appl Pharmacol<\/i>, 87, pp. 185 - 205. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1539-6924.1993.tb00731.x","volume":"13","author":"Fisher J","year":"1993","unstructured":"Fisher, J and Allen, B. (1993) Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models Risk Anal<\/i>, 13, pp. 87 - 95. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>","journal-title":"Risk Anal"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0048-9697(01)00730-6","volume":"274","author":"Clewell H","year":"2001","unstructured":"Clewell, H and Gentry, P and Gearhart, J and Allen, B and Andersen, M. (2001) Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model Sci Total Environ<\/i>, 274(1\u20133), pp. 37 - 66. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Sci Total Environ"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/taap.1996.0079","volume":"137","author":"Reitz R","year":"1996","unstructured":"Reitz, R and Gargas, M and Andersen, M and Provan, W and Green, T. (1996) Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model Toxicol Appl Pharmacol<\/i>, 137, pp. 253 - 267. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0041-008X(78)90266-1","volume":"44","author":"Gehring P","year":"1978","unstructured":"Gehring, P and Watanabe, P and Park, C. (1978) Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example\u2013vinyl chloride Toxicol Appl Pharmacol<\/i>, 44(3), pp. 581 - 591. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0021-9258(18)85258-9","volume":"59","author":"Haggard H","year":"1924","unstructured":"Haggard, H. (1924) The absorption, distribution and elimination of ethyl ether. Analysis of the mechanism of the absorption and elimination of such a gas or vapor as ethyl ether J Biol Chem<\/i>, 59, pp. 753 - 770.","journal-title":"J Biol Chem"},{"key":"E00014","first-page":"1","volume":"3","author":"Kety S","year":"1951","unstructured":"Kety, S. (1951) The theory and application of the exchange of inert gas at the lungs Pharmacol Rev<\/i>, 3, pp. 1 - 41. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Pharmacol Rev"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1152\/jappl.1963.18.1.197","volume":"18","author":"Mapleson W","year":"1963","unstructured":"Mapleson, W. (1963) An electric analog for uptake and elimination in man J Appl Physiol<\/i>, 18, pp. 197 - 204. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Appl Physiol"},{"key":"E00016","first-page":"201","volume":"32","author":"Fiserova-Bergerova V","year":"1975","unstructured":"Fiserova-Bergerova, V. (1975) Mathematical modeling of inhalation exposure J Combustion Toxicol<\/i>, 32, pp. 201 - 210.","journal-title":"J Combustion Toxicol"},{"key":"E00017","first-page":"193","author":"KrishnanK","year":"2001","unstructured":"Krishnan, K and Andersen, M.(2001) Physiologically-based pharmacokinetic modeling in toxicology. In Principles and Methods of Toxicology<\/i>. ( pp. 193 - 241 ). Philadelphia PA: Taylor & Francis."},{"key":"E00018","first-page":"159","volume":"8","author":"Clewell H","year":"1987","unstructured":"Clewell, H and Andersen, M. (1987) Dose, species and route extrapolation using physiologically-based pharmacokinetic models Drinking Water and Health<\/i>, 8, pp. 159 - 182.","journal-title":"Drinking Water and Health"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3835(93)90025-5","volume":"69","author":"Andersen M","year":"1993","unstructured":"Andersen, M and Krewski, D and Withey, J. (1993) Physiological pharmacokinetics and cancer risk assessment Cancer Lett<\/i>, 69, pp. 1 - 14. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CROSSREF]<\/a>","journal-title":"Cancer Lett"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1289\/ehp.94102s1103","volume":"102","author":"Andersen M","year":"1994","unstructured":"Andersen, M and Krishnan, K. (1994) Physiologically based pharmacokinetics and cancer risk assessment Environ Health Perspect<\/i>, 102, pp. 103 - 108. (Suppl 1)[PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Environ Health Perspect"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1081\/DMR-100100572","volume":"32","author":"Melnick R","year":"2000","unstructured":"Melnick, R and Kohn, M. (2000) Dose-response analyses of experimental cancer data Drug Metab Rev<\/i>, 32, pp. 193 - 209. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Drug Metab Rev"},{"year":"2003","author":"US EPA","key":"E00022","unstructured":"US EPA.(2003) Guidelines for Carcinogen Risk Assessment, Final Draft<\/i>. Washington : Environmental Protection Agency, Office of Research and Development. NCEA-F-0644"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/taap.1996.8096","volume":"144","author":"Tardif R","year":"1997","unstructured":"Tardif, R and Charest-Tardif, G and Brodeur, J and Krishnan, K. (1997) Physiologically-based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans Toxicol Appl Pharmacol<\/i>, 144, pp. 120 - 134. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1539-6924.1994.tb00238.x","volume":"14","author":"Jarabek A","year":"1994","unstructured":"Jarabek, A and Fisher, J and Rubenstein, R and Lipscomb, J and Wills, R and Vinegar, A and McDougal, J. (1994) Mechanistic insights aid the search for CFC Substitutes: Risk assessment of HCFC-123 as an example Risk Analysis<\/i>, 14, pp. 231 - 250. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>","journal-title":"Risk Analysis"},{"year":"1990","author":"GerrityT","key":"E00025","unstructured":"Gerrity, T and Henry, C and Birnbaum, L.(1990) Principles of Route-to-Route extrapolation for risk assessment<\/i>. New York : Elsevier."},{"key":"E00026","first-page":"335","author":"KrishnanK","year":"1991","unstructured":"Krishnan, K and Andersen, M.(1991) Physiological modeling and cancer risk assessment. In New Trends in Pharmacokinetics<\/i>. ( pp. 335 - 354 ). NY : Plenum Press."},{"key":"E00027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/0272-4332.00013","volume":"20","author":"Kirman C","year":"2000","unstructured":"Kirman, C and Hays, S and Kedderis, G and Gargas, M and Strother, D. (2000) Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat Risk Anal<\/i>, 20(1), pp. 135 - 151. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Risk Anal"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/toxsci\/71.2.176","volume":"71","author":"Poet T","year":"2003","unstructured":"Poet, T and Soelberg, J and Weitz, K and Mast, T and Miller, A and Thrall, B and Corley, R. (2003) Mode of action and pharmacokinetic studies of 2-butoxyethanol in the mouse with an emphasis on forestomach dosimetry Toxicol Sci<\/i>, 71, pp. 176 - 189. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Sci"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0041-008X(90)90148-N","volume":"105","author":"Reitz R","year":"1990","unstructured":"Reitz, R and Mandrela, A and Corley, R and Quast, J and Gargas, M and Andersen, M and Staats, D and Conolly, R. (1990) Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically-based pharmacokinetic modeling Toxicol Appl Pharmacol<\/i>, 105, pp. 443 - 459. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10937400290070080","volume":"5","author":"Meek M","year":"2002","unstructured":"Meek, M and Beauchamp, R and Long, G and Turner, L and Walker, M. (2002) Chloroform: Exposure estimation, hazard characterization, and exposure-response Analysis J Toxicol Environ Health<\/i>, 5(B), pp. 283 - 334.","journal-title":"J Toxicol Environ Health"},{"key":"E00031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/faat.1996.0081","volume":"31","author":"Casanova M","year":"1996","unstructured":"Casanova, M and Conolly, R and Heck, H. (1996) DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: Pharmacokinetics and risk assessment with DPX as dosimeter Fund Appl Toxicol<\/i>, 31, pp. 103 - 116. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Fund Appl Toxicol"},{"key":"E00032","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/1539-6924.00328","volume":"23","author":"Schlosser P","year":"2003","unstructured":"Schlosser, P and Patrick, D and Conolly, R and Janszen, D and Kimbell, J. (2003) Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses Risk Analysis<\/i>, 23, pp. 473 - 487. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Risk Analysis"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/57.2.312","volume":"57","author":"Andersen M","year":"1999","unstructured":"Andersen, M and Sarangapani, R and Gentry, P and Clewell, H, III and Covington, TR and Frederick, C. (1999) Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid Toxicol Sci<\/i>, 57, pp. 312 - 325. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Sci"},{"key":"E00034","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/rtph.2002.1576","volume":"36","author":"Andersen M","year":"2002","unstructured":"Andersen, M and Green, T and Frederick, C and Bogdanffy, M. (2002) Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate Regul Toxicol Pharmacol<\/i>, 36, pp. 234 - 245. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Regul Toxicol Pharmacol"},{"key":"E00035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/rtph.2002.1545","volume":"35","author":"Cruzen G","year":"2002","unstructured":"Cruzen, G and Carlson, G and Johnson, K and Andrews, L and Banton, M and Bevan, C and Cushman, J. (2002) Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites Reg Toxicol Pharmacol<\/i>, 35, pp. 308 - 319. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Reg Toxicol Pharmacol"},{"key":"E00036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/toxsci\/51.1.19","volume":"51","author":"Bogdanffy M","year":"1999","unstructured":"Bogdanffy, M and Sarangapani, R and Plowchalk, D and Jarabek, A and Andersen, M. (1999) A biologically-based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity Toxicol Sci<\/i>, 51, pp. 19 - 35. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Sci"},{"key":"E00037","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/08958370151126266","volume":"13","author":"Bogdanfy M","year":"2001","unstructured":"Bogdanfy, M and Plowchalk, D and Sarangapani, R and Starr, T and Andersen, M. (2001) Mode-of-action-based dosimeters for interspecies extrapolation on vinyl acetate inhalation risk Inhal Toxicol<\/i>, 13, pp. 377 - 396. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Inhal Toxicol"},{"key":"E00038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-4274(88)90023-9","volume":"43","author":"Reitz R","year":"1988","unstructured":"Reitz, R and Mandrela, A and Park, C and Andersen, M and Guengerich, F. (1988) Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PBPK) model for methylene chloride: Implications for risk assessment Toxicol Lett<\/i>, 43, pp. 97 - 116. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Lett"},{"key":"E00039","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1289\/ehp.94102s1161","volume":"102","author":"Spear R","year":"1994","unstructured":"Spear, R and Bois, F. (1994) Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results Environ Health Perspect<\/i>, 102, pp. 61 - 66. (Suppl.11)[PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Environ Health Perspect"},{"key":"E00040","first-page":"1405","volume":"104","author":"Bois F","year":"1996","unstructured":"Bois, F and Jackson, E and Pekari, K and Smith, M. (1996) Population toxicokinetics of benzene Environ Health Perspect<\/i>, 104, pp. 1405 - 1411. (Suppl.6)[PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Environ Health Perspect"},{"key":"E00041","doi-asserted-by":"crossref","first-page":"S883","DOI":"10.1289\/ehp.00108s5883","volume":"108","author":"Bernillon P","year":"2000","unstructured":"Bernillon, P and Bois, F. (2000) Statistical issues in toxicokinetic modeling: a Bayesian perspective Environ. Health Perspect Suppl<\/i>, 108, pp. S883 - S893.","journal-title":"Environ. Health Perspect Suppl"},{"key":"E00042","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1289\/ehp.94102s1161","volume":"174","author":"Jonsson F","year":"2001","unstructured":"Jonsson, F and Johanson, G. (2001) A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane Toxicol Appl Pharmacol<\/i>, 174, pp. 99 - 112. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00043","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/taap.2001.9331","volume":"179","author":"Jonsson F","year":"2002","unstructured":"Jonsson, F and Johanson, G. (2002) Physiologically-based modeling of the inhalation kinetics of styrene in humans using a Bayesian population approach Toxicol Appl Pharmacol<\/i>, 179(1), pp. 35 - 49. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00044","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2307\/2986121","volume":"43","author":"Wakefield J","year":"1994","unstructured":"Wakefield, J and Smith, A. (1994) Bayesian analysis of linear and non-linear population models by using the Gibbs sample Appl Stat<\/i>, 43, pp. 201 - 221.","journal-title":"Appl Stat"},{"key":"E00045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-4274(02)00369-7","author":"Jonsson F","year":"2003","unstructured":"Jonsson, F and Johanson, G. (2003) The Bayesian population approach to physiological toxicokinetic - toxicodynamic models - an example using the MCSim software Toxicol Lett<\/i>, pp. 143 - 150. [CROSSREF]<\/a>","journal-title":"Toxicol Lett"},{"key":"E00046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/taap.1999.8715","volume":"158","author":"El-Masri H","year":"1999","unstructured":"El-Masri, H and Bell, D and Portier, C. (1999) Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans Toxicol Appl Pharmacol<\/i>, 158, pp. 221 - 230. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00047","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1539-6924.00287","volume":"23","author":"Ginsberg G","year":"2003","unstructured":"Ginsberg, G. (2003) Assessing cancer risks from short-term exposures in children Risk Anal<\/i>, 23(1), pp. 19 - 34. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Risk Anal"},{"key":"E00048","first-page":"333","volume":"112","author":"Gladtke E","year":"1973","unstructured":"Gladtke, E. (1973) Pharmacokinetics in relation to age Boll Chim Farm<\/i>, 112, pp. 333 - 341. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Boll Chim Farm"},{"key":"E00049","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/toxsci\/66.2.185","volume":"66","author":"Ginsberg G","year":"2002","unstructured":"Ginsberg, G and Hattis, D and Sonawane, B and Russ, A and Banati, P and Kozlak, M and Smolenski, S and Goble, R. (2002) Evaluation of child\/adult pharmacokinetic differences from a database derived from the therapeutic drug literature Toxicol Sci<\/i>, 66, pp. 185 - 200. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Sci"},{"key":"E00050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/20024091064264","volume":"32","author":"Clewell H","year":"2002","unstructured":"Clewell, H and Teeguarden, J and McDonald, T and Sarangapani, R and Lawrence, G and Covington, T and Gentry, R and Shipp, A. (2002) Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry Crit Rev Toxicol<\/i>, 32(5), pp. 329 - 389. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>","journal-title":"Crit Rev Toxicol"},{"key":"E00051","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/152873901753215911","volume":"64","author":"Haddad S","year":"2001","unstructured":"Haddad, S and Restieri, C and Krishnan, K. (2001) Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans J Toxicol Environ Health<\/i>, 64(A), pp. 453 - 464. [CROSSREF]<\/a>","journal-title":"J Toxicol Environ Health"},{"key":"E00052","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0169-409X(03)00030-9","volume":"55","author":"Alcorn J","year":"2003","unstructured":"Alcorn, J and McNamara, P. (2003) Pharmacokinetics in the newborn Adv Drug Delivery Rev<\/i>, 55, pp. 667 - 686. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Adv Drug Delivery Rev"},{"key":"E00053","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1472-8206.2003.00140.x","volume":"17","author":"Strolin Benedetti M","year":"2003","unstructured":"Strolin Benedetti, M and Baltes, E. (2003) Drug metabolism and disposition in children Fund Clin Pharmacol<\/i>, 17, pp. 281 - 299. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Fund Clin Pharmacol"},{"key":"E00054","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/15287390306450","volume":"66","author":"Price K","year":"2003","unstructured":"Price, K and Haddad, S and Krishnan, K. (2003) Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children J Toxicol Environ Health<\/i>, 66, pp. 417 - 433. (Part A)[CROSSREF]<\/a>","journal-title":"J Toxicol Environ Health"},{"key":"E00055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yrtph.2004.02.006","volume":"39","author":"Zwart L","year":"2004","unstructured":"Zwart, L, De and Haenen, HEMG and Versantvoort, C and Wolterink, G and Van Engelen, J. (2004) Sips AJAM. Role of biokinetics in risk Assessment of drugs and chemicals in children Regul Toxicol Pharmacol<\/i>, 39(3), pp. 282 - 309. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Regul Toxicol Pharmacol"},{"key":"E00056","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/toxsci\/kfh109","volume":"79","author":"Clewell H","year":"2004","unstructured":"Clewell, H and Gentry, P and Covington, T and Sarangapani, R and Teeguarden, J. (2004) Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry Toxicol Sci<\/i>, 79, pp. 381 - 393. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Toxicol Sci"},{"key":"E00057","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/15287390490273550","volume":"67","author":"Ginsberg G","year":"2004","unstructured":"Ginsberg, G and Hattis, D and Russ, A and Sonawane, B. (2004) Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: Implications for assessing children's risks from environmental agents J Toxicol Environ Health Part A<\/i>, 67, pp. 297 - 329. [CSA]<\/a>","journal-title":"J Toxicol Environ Health Part A"},{"key":"E00058","first-page":"117","volume":"23","author":"Hattis D","year":"2003","unstructured":"Hattis, D and Ginsberg, G and Sonawane, B and Smolenski, S and Russ, A and Kozlak, M and Goble, R. (2003) Differences in pharmacokinetics between children and adults - II Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal<\/i>, 23, pp. 117 - 142. [CSA]<\/a>","journal-title":"Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal"},{"key":"E00059","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1289\/ehp.94102s9113","volume":"102","author":"Woo Y-T","year":"1994","unstructured":"Woo, Y-T and Carlo, F, Di and Arcos, J and Argus, M and Polansky, G and Du Bose, J. (1994) Assessment of carcinogenic hazard of chemical mixtures through analysis of binary chemical interaction data Environ Health Perspect<\/i>, 102, pp. 113 - 118. (Suppl. 9)[PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Environ Health Perspect"},{"year":"2000","author":"U.S. EPA. Supplemental guidance for conducting health risk assessment of chemical mixtures","key":"E00060","unstructured":"U.S. EPA. Supplemental guidance for conducting health risk assessment of chemical mixtures.(2000) Risk Assessment Forum, US E.P.A.<\/i>. Washington DC"},{"key":"E00061","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1289\/ehp.94102s9151","volume":"102","author":"Krishnan K","year":"1994","unstructured":"Krishnan, K and Clewell, H and Andersen, M. (1994) Physiologically based pharmacokinetic analysis of simple mixtures Environ Health Perspectives<\/i>, 102, pp. 151 - 155. [CSA]<\/a>","journal-title":"Environ Health Perspectives"},{"key":"E00062","first-page":"82","author":"Yang R","year":"1995","unstructured":"Yang, R and El-Masri, H and Thomas, R and Constan, A. (1995) The use of physiologically-based pharmacokinetic pharmacodynamic dosimetry models for chemical mixtures Toxicol Lett<\/i>, pp. 82 - 83. 497\u2013504","journal-title":"Toxicol Lett"},{"key":"E00063","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0278-6915(97)00076-8","volume":"34","author":"Simmons J","year":"1996","unstructured":"Simmons, J. (1996) Application of physiologically based pharmacokinetic modelling to combination toxicology Food Chem Toxicol<\/i>, 34(11\u201312), pp. 1067 - 1073. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Food Chem Toxicol"},{"key":"E00064","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1289\/ehp.021101031","volume":"110","author":"Dobrev I","year":"2002","unstructured":"Dobrev, I and Andersen, M and Yang, R. (2002) In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane Environ Health Perspect<\/i>, 110(10), pp. 1031 - 1039. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>","journal-title":"Environ Health Perspect"},{"key":"E00065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/taap.1999.8803","volume":"161","author":"Haddad S","year":"1999","unstructured":"Haddad, S and Tardif, R and Charest-Tardif, G and Krishnan, K. (1999) Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons Toxicol Appl Pharmacol<\/i>, 161(3), pp. 249 - 257. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00066","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/taap.2000.8991","volume":"167","author":"Haddad S","year":"2000","unstructured":"Haddad, S and Charest-Tardif, G and Tardif, R and Krishnan, K. (2000) Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures Toxicol Appl Pharmacol<\/i>, 167, pp. 199 - 209. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Appl Pharmacol"},{"key":"E00067","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/toxsci\/63.1.125","volume":"63","author":"Haddad S","year":"2001","unstructured":"Haddad, S and Beliveau, M and Tardif, R and Krishnan, K. (2001) A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures Toxicol Sci<\/i>, 63(1), pp. 125 - 131. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>[CROSSREF]<\/a>","journal-title":"Toxicol Sci"},{"key":"E00068","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1289\/ehp.98106s61377","volume":"106","author":"Haddad S","year":"1998","unstructured":"Haddad, S and Krishnan, K. (1998) Physiological modeling of toxicokinetic interactions: Implications for mixture risk assessment Environ Health Perspect<\/i>, 106(Suppl. 6), pp. 1377 - 1384. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Environ Health Perspect"},{"year":"1993","author":"BlancatoJ","key":"E00069","unstructured":"Blancato, J and Chiu, N.(1993) Predictive modeling for uptake and tissue distribution from human exposures. In Safety of Water Disinfection: Balancing Chemical & Microbial Risks<\/i>. . Washington D.C.: ILSI Press."},{"key":"E00070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/15287390252807957","volume":"65","author":"L\u00e9vesque B","year":"2002","unstructured":"L\u00e9vesque, B and Ayotte, P and Tardif, R and Ferron, L and Gingras, S and Schlouch, E and Gingras, G and Levallois, P and Dewailly, E. (2002) Cancer risk associated with household exposure to chloroform J Toxicol Environ Health Part A<\/i>, 65, pp. 489 - 502. [CSA]<\/a>[CROSSREF]<\/a>","journal-title":"J Toxicol Environ Health Part A"},{"key":"E00071","unstructured":"http:\/\/www.hc-sc.gc.ca\/hecs-sesc\/water\/pdf\/trihalomethanes_drinking_water.pdf Health Canada. Trihalomethanes in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON. 2004. Health Canada. Trihalomethanes in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON. 2004."},{"year":"1988","author":"BoganK","key":"E00072","unstructured":"Bogan, K and Hall, L and Perry, L and Fish, R and Mckone, T and Dowd, P and Patton, S and Mallon, B.(1988) Health risk assessment of trichloroethylene (TCE) in California drinking water<\/i>. Livermore CA: Environmental Sciences Division, Lawrence Livermore National Laboratory, University of California."},{"key":"E00073","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1289\/ehp.9610448","volume":"104","author":"Weisel C","year":"1996","unstructured":"Weisel, C and Jo, W. (1996) Ingestion, Inhalation and dermal exposures to chloroform and trichloroethene from tap water Environ Health Perspect<\/i>, 104, pp. 48 - 51. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CSA]<\/a>","journal-title":"Environ Health Perspect"},{"key":"E00074","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/10473289.1996.10467541","volume":"46","author":"Lindstrom A","year":"1996","unstructured":"Lindstrom, A and Pleil, J. (1996) A methodological approach for exposure assessment studies in residence using volatile organic compound-contaminated water J Air Waste Manage Assoc<\/i>, 46(11), pp. 1058 - 1066. [CSA]<\/a>","journal-title":"J Air Waste Manage Assoc"},{"key":"E00075","unstructured":"http:\/\/www.hc-sc.gc.ca\/hecs-sesc\/water\/pdf\/TCE-Consultation.pdf Health Canada. Trichloroethylene in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON. 2004; Health Canada. Trichloroethylene in drinking water. Document for public comment. Federal-Provincial-Territorial Committee on Drinking Water, Ottawa, ON. 2004;"}],"container-title":["Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis & Ecotoxicology Reviews"],"original-title":[],"link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1081\/GNC-200051856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:40:12Z","timestamp":1626482412000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.informaworld.com\/openurl?genre=article&doi=10.1081\/GNC-200051856&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,6]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4,6]]}},"alternative-id":["U64748R027K0X277"],"URL":"https:\/\/doi.org\/10.1081\/gnc-200051856","relation":{},"ISSN":["1059-0501","1532-4095"],"issn-type":[{"type":"print","value":"1059-0501"},{"type":"electronic","value":"1532-4095"}],"subject":[],"published":{"date-parts":[[2005,4,6]]}}}